GURNET POINT CAPITAL
Gurnet Point Capital is a leading healthcare fund that invests in de-risked life sciences companies. Gurnet Point primarily focuses on businesses that have high growth potential in the late product development and commercialization stages of their evolution. These companies become partners not just because of their capacity to generate economic value, but also because of their potential to deliver social impact. Gurnet Point’s team of highly experienced industry executives work closely with its portfolio companies, with an active approach driving operational transformation and outsized returns. www.gurnetpointcapital.com
GURNET POINT CAPITAL
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2015-01-01
Status:
Active
Contact:
617-588-4900
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome Apache
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Advisor
Advisor
2018-06-01
Current Employees Featured
Ernesto Bertarelli Founder @ Gurnet Point Capital
Founder
Travis Read Principal @ Gurnet Point Capital
Principal
2016-01-01
Travis Wilson Partner @ Gurnet Point Capital
Partner
2016-01-01
David Moore Partner @ Gurnet Point Capital
Partner
2020-03-01
Michael Vigilante Principal @ Gurnet Point Capital
Principal
2016-01-01
Alex Tsoukas Principal @ Gurnet Point Capital
Principal
2022-07-01
Anne Stone Principal @ Gurnet Point Capital
Principal
2014-06-01
Anne Stone Principal @ Gurnet Point Capital
Principal
2014-06-01
Travis Wilson Partner @ Gurnet Point Capital
Partner
2016-01-01
Alex Tsoukas Principal @ Gurnet Point Capital
Principal
2022-07-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-23 | Radius Health | Radius Health acquired by Gurnet Point Capital | 890 M USD |
| 2018-10-11 | Corium International | Corium International acquired by Gurnet Point Capital | 504 M USD |
| 2017-04-04 | Innocoll Holdings | Innocoll Holdings acquired by Gurnet Point Capital | 209 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-22 | Alladapt Immunotherapeutics | Gurnet Point Capital investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2020-12-15 | Naveris | Gurnet Point Capital investment in Series A - Naveris | N/A |
| 2020-12-09 | Tremeau Pharmaceuticals | Gurnet Point Capital investment in Private Equity Round - Tremeau Pharmaceuticals | N/A |
| 2020-02-20 | Alladapt Immunotherapeutics | Gurnet Point Capital investment in Series C - Alladapt Immunotherapeutics | 60 M USD |
| 2017-03-20 | BEFORE Brands | Gurnet Point Capital investment in Series B - BEFORE Brands | 35 M USD |
| 2016-12-07 | Crossover Health | Gurnet Point Capital investment in Venture Round - Crossover Health | 92 M USD |
| 2016-12-01 | Auregen BioTherapeutics | Gurnet Point Capital investment in Venture Round - Auregen BioTherapeutics | N/A |
| 2016-10-05 | BEFORE Brands | Gurnet Point Capital investment in Series A - BEFORE Brands | 13.1 M USD |
More informations about "Gurnet Point Capital"
Gurnet Point Capital - Crunchbase Investor Profile & Investments
Gurnet Point Capital is a leading healthcare fund that invests in de-risked life sciences companies. Gurnet Point primarily focuses on businesses that have high growth potential in the late …See details»
About | Gurnet Point Capital
Gurnet Point Capital, headquartered in Cambridge, MA, was founded in 2015, and pursues control-oriented investments in scientifically de-risked life sciences businesses. Gurnet Point …See details»
Gurnet Point Capital - Investments, Portfolio & Company Exits
Oct 20, 2022 Gurnet Point Capital has made 11 investments. Their most recent investment was on Oct 20, 2022 , when Corium raised Gurnet Point Capital has made 4 diversity investments. …See details»
Gurnet Point Capital - LinkedIn
Gurnet Point Capital | 1,530 followers on LinkedIn. Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve ...See details»
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital …
Jun 6, 2023 Under the terms of the merger agreement, Gurnet Point, a leading healthcare investment firm, and Novo Holdings, a holding and investment company responsible for …See details»
Gurnet Point Capital Completes Acquisition of Corium ... - B …
CAMBRIDGE, Mass., November 27, 2018 -- Gurnet Point Capital (“Gurnet Point”), a private investment firm focused on the healthcare and life sciences sectors, ... We intend to establish …See details»
Gurnet Point Capital - Private Equity Investments & Executives
See Gurnet Point Capital's 11 investments, 9 executives, and complete investor profile. Founded in 2015, Gurnet Point Capital is an investment fund that enables established healthcare and …See details»
Investments - Gurnet Point Capital
Gurnet Point Capital © 2023. Please take a moment to read the Legal Notice / Privacy Statement.Legal Notice / Privacy Statement.See details»
Corium and Gurnet Point Capital Announce …
Oct 20, 2022 Gurnet Point Capital and Webster will be investors in each of the two companies. ... Corium Pharma Solutions, a contract development & manufacturing organization (“CDMO”), and Corium, a ...See details»
Gurnet Point Capital - Contacts, Employees, Board Members
Gurnet Point Capital has 12 current employee profiles, including Founder Ernesto Bertarelli. Gurnet Point Capital has 1 board member or advisor, Sophie Kornowski. Contacts. Edit …See details»
Gurnet Point Capital and Novo Holdings A/S Complete Acquisition …
Sep 21, 2023 Under the terms of the merger agreement, Gurnet Point, a leading healthcare investment firm, and Novo Holdings, a holding and investment company responsible for …See details»
Corium and Gurnet Point Capital Announce Manufacturing …
Oct 21, 2022 Corium, LLC a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Gurnet Point Capital …See details»
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital …
Jun 6, 2023 Gurnet Point Capital Blair Hennessy Abernathy H/Advisors Email: blair.hennessy@h-advisors.global Phone: (212) 371-5999. Novo Holdings Dora González …See details»
Fenwick Represents Corium in Pending $504 Million… | Fenwick
Oct 11, 2018 Fenwick & West represented Corium International, Inc. (Nasdaq: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and …See details»
Gurnet Point Capital - Funding, Financials, Valuation & Investors
Gurnet Point Capital has raised a total of $1.5B in a single venture fund, Gurnet Point Capital Fund. This fund was announced on Jun 23, 2015 and raised a total of . obfuscated. …See details»
Manufacturing Business Acquisition and a $100 ... - Gurnet Point …
Gurnet Point Capital and Webster will be investors in each of the two companies ... Corium Pharma Solutions, a contract development & manufacturing organization (“CDMO”), and …See details»
Corium Innovations - Gurnet Point Capital
Oct 20, 2022 Corium Innovations, Inc. is a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, including …See details»
Gurnet Point Capital and Patient Square Capital Complete Their ...
Cambridge, Mass., August 15, 2022 – Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Square”) announced today the completion of their acquisition of Radius …See details»
News - Gurnet Point Capital
Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings. Read. June 6, 2023 Corium Pharma Solutions, Inc. is Now Corium Innovations, Inc. Read. April 12, 2023 …See details»